Global Exporter & Bulk Supplier of Alimlieva 500 mg Injection

🌍 Introduction

Are you seeking a reliable and globally compliant exporter of Alimlieva 500 mg Injection? At Ernest Oncology (a division of Ernest Pharmaceutical Pvt. Ltd.), we specialize in the secure, compliant, and efficient supply chain management and distribution of critical oncology formulations, including Pemetrexed 500 mg injections, to hospitals, pharmacies, and pharmaceutical distributors worldwide.

🔬 1. Product Overview: Alimlieva 500 mg Injection

Alimlieva 500 mg Injection contains Pemetrexed, a potent multi-targeted folate antimetabolite antineoplastic agent widely used in the treatment of solid tumors, primarily in the chest and lungs.

• Composition: Pemetrexed Disodium equivalent to Pemetrexed 500 mg

• Therapeutic Class: Anti-folate antineoplastic agent / Antimetabolite

• Formulation Type: Lyophilized powder for sterile Intravenous (IV) infusion

• Storage Temperature: Store in a refrigerator (2°C – 8°C). Do not freeze.

⚙️ 2. Mechanism of Action

Alimlieva functions as an antifolate agent that disrupts the metabolic and genetic processes of cancer cells:

• Enzyme Inhibition: Pemetrexed inhibits three key folate-dependent enzymes: thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT).

• DNA/RNA Interference: By blocking these enzymes, the drug prevents the synthesis of purine and pyrimidine nucleotides, which are the essential building blocks for DNA and RNA.

• Cell Cycle Arrest: The inability to synthesize DNA stops the rapid multiplication and growth of cancer cells, ultimately leading to programmed cell death (apoptosis).

🏥 3. Therapeutic Indications

Alimlieva 500 mg Injection is clinically indicated for:

• Non-Small Cell Lung Cancer (NSCLC): Used as first-line, maintenance, or second-line therapy for advanced or metastatic non-squamous non-small cell lung cancer.

• Malignant Pleural Mesothelioma: Indicated in combination with cisplatin for the treatment of patients with mesothelioma (cancer of the lung lining) that is unresectable or not suitable for surgery.

⚠️ 4. Administration & Safety Guidelines

• Route of Administration: Alimlieva is administered exclusively via Intravenous (IV) infusion by a qualified medical professional.

• Pre-medication Protocol: Patients must be pre-treated with folic acid, vitamin B12, and corticosteroids to reduce the risk of skin and hematologic toxicities.

• Side Effects & Precautions: Common side effects include fatigue, nausea, vomiting, loss of appetite, and rash. Serious risks include bone marrow suppression (low blood cell counts) and kidney issues.

• Fertility Note: This medication may affect fertility; patients should consult their doctor regarding sperm storage or contraception before starting therapy.

PRESCRIPTION MEDICINE IS YES